What we found on the web about Bristol-Myers Squibb
Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company ...
Pages in category "Bristol-Myers Squibb" The following 29 pages are in this category, out of 29 total. This list may sometimes be slightly out of date ...
Welcome to Bristol-Myers Squibb's Clinical Trials Disclosure website. Bristol-Myers Squibb is committed to providing transparency into clinical trial ...
Bristol-Myers Squibb Company was incorporated under the laws of the State of Delaware in August 1933 under the name Bristol-Myers Company, as successor to a New York business ...
The Bristol-Myers Squibb Patient Assistance Foundation, Inc. is a non-profit organization. The Foundation was established in 1998 to provide temporary assistance to qualifying ...
Bristol-Myers Squibb (BMY) will release first-quarter results on April 24. BMY ... With a yield of 5.6%, Bristol-Myers Squibb is an industry standout as very few ...
Get detailed information on BRISTOL MYERS SQIBB (BMY) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the latest company ...
Bristol-Myers Squibb is a global pharmaceutical company whose mission is to extend and enhance human life by developing innovative medicines and health care products.
Get the latest on Bristol Myers Squibb Co. (BMY) including stock quotes, interactive charts, up to date news, high quality discussion groups and more on Google Finance.
Bristol-Myers Squibb Co. Industry: Medical-DrugsAdd Security to your Watch List ... Bristol-Myers Squibb Company is a diversified worldwide health and personal care ...
Get detailed information on BRISTOL MYERS SQIBB (BMY) including quote performance, Real-Time ECN, technical chart ... Bristol-Myers Squibb and Capital ...
Bristol-Myers Squibb to Commence Cash Tender Offer for ImClone Systems at $62.00 ... Bristol-Myers Squibb Announces Filing of IPO Registration Statement for Mead ...
Bristol-Myers Squibb Company was incorporated under the laws of the State of Delaware in August 1933 under the name Bristol-Myers Company, as successor to a New York business ...
Here is what users have to say about Bristol-Myers Squibb

Bristolmyersprincetonfacility.jpg

Bristol-Myers Squibb (nyse: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were graduates of Hamilton College), and Squibb Corporation. The New York City-based company's Chairman and CEO was most recently Peter R. Dolan. Dolan was fired in September 2006 for his handling of a patent dispute over the drug Plavix, and was replaced with interim CEO James Cornelius. Since that time, Mr. Cornelius has assumed the permanent role of CEO and Chairman upon the retirement of James Robinson, III. Mr. Robinson was appointed Chairman as part of the settlement regarding the "channel-stuffing" scandal (see Scandals and allegations). BMS' primary R&D sites are located in Lawrenceville, New Jersey (formerly Squibb) and Wallingford, Connecticut (formerly Bristol-Myers), with other sites around the US, in Ireland and in other countries. Mr. Cornelius has embarked on a major restructuring of the company which involves focusing on biologic products along with multi-year headcount reductions through layoffs and attrition of employees, and the outsourcing and off-shoring of operations. A significant move will be made to replace US R&D with inexpensive operations in India and China.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Bristol-Myers Squibb
BusinessWeek
With 11 HIV medicines already on sale, the new venture would have a 19 percent market share, ranking it No. 2 behind sales leader Gilled Sciences Inc. Other competitors in the field include heavyweights Bristol-Myers Squibb Co., Abbott Labo...
Earthtimes
NEW YORK - (Business Wire) Bristol-Myers Squibb Company (NYSE:BMY) announced today that belatacept, an investigational co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of nine company-sponsore...
PR Inside
Bristol-Myers Squibb Company : (NYSE:BMY) will present at the Bernstein Strategic Decisions Conference on Wednesday, May 27, 2009 in New York. Jim Cornelius : , chairman and chief executive officer of Bristol-Myers Squibb, will make a forma...
BusinessWeek
It reported $29.6 million in revenue last year from collaborations with Bristol-Myers Squibb Co., Wyeth, and Genentech Inc. Shares of Exelixis spiked $1.33, or 29.5 percent, to $5.84 in premarket activity. Its shares have ranged from $2.11 ...
Indianapolis Business Journal
MONTGOMERY, Ala. The state of Alabama has settled Medicaid drug pricing lawsuits it filed against drugmaker Bristol-Myers Squibb and four other companies.